BioCentury
ARTICLE | Clinical News

Theratope therapeutic vaccine: A Phase II trial

October 17, 1994 7:00 AM UTC

Biomira Inc. (BRA), Edmonton, Alberta Product: Theratope therapeutic vaccine with synthetic cancer antigens Indication: Breast and colorectal cancer Status: A Phase II trial will start in November in...